Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Jaaro-Peled H, Niwa M, Foss CA, Murai R, de Los Reyes S, Kamiya A, Mateo Y, O'Donnell P, Cascella NG, Nabeshima T, Guilarte TR, Pomper MG, Sawa A.

Hum Mol Genet. 2013 Apr 15;22(8):1574-80. doi: 10.1093/hmg/ddt007. Epub 2013 Jan 11.

2.

Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice.

Kim J, Horti AG, Mathews WB, Pogorelov V, Valentine H, Brasic JR, Holt DP, Ravert HT, Dannals RF, Zhou L, Jedynak B, Kamiya A, Pletnikov MV, Wong DF.

Mol Imaging Biol. 2015 Jun;17(3):355-63. doi: 10.1007/s11307-014-0786-4.

PMID:
25296765
3.
4.

In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy.

Yakushev IY, Dupont E, Buchholz HG, Tillmanns J, Debus F, Cumming P, Heimann A, Fellgiebel A, Luhmann HJ, Landvogt C, Werhahn KJ, Schreckenberger M, Potschka H, Bartenstein P.

Epilepsia. 2010 Mar;51(3):415-22. doi: 10.1111/j.1528-1167.2009.02272.x. Epub 2009 Aug 19.

5.

Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.

Lipina TV, Niwa M, Jaaro-Peled H, Fletcher PJ, Seeman P, Sawa A, Roder JC.

Genes Brain Behav. 2010 Oct;9(7):777-89. doi: 10.1111/j.1601-183X.2010.00615.x. Epub 2010 Aug 12.

6.

Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.

Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.

Neuroimage. 2013 Nov 15;82:252-9. doi: 10.1016/j.neuroimage.2013.05.091. Epub 2013 May 28.

PMID:
23727314
7.

Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.

Cervenka S, Gustavsson JP, Halldin C, Farde L.

Neuroimage. 2010 Mar;50(1):323-8. doi: 10.1016/j.neuroimage.2009.12.006. Epub 2009 Dec 11.

PMID:
20004254
8.

Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.

Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya A, Cadet JL, Wong DF, Pletnikov MV.

Neuropharmacology. 2012 Mar;62(3):1242-51. doi: 10.1016/j.neuropharm.2011.02.003. Epub 2011 Feb 17.

9.

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, Lai RY, Halldin C, Farde L.

Brain. 2006 Aug;129(Pt 8):2017-28. Epub 2006 Jul 1.

PMID:
16816393
10.

The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Christian BT, Vandehey NT, Fox AS, Murali D, Oakes TR, Converse AK, Nickles RJ, Shelton SE, Davidson RJ, Kalin NH.

Neuroimage. 2009 Feb 15;44(4):1334-44. doi: 10.1016/j.neuroimage.2008.10.020. Epub 2008 Oct 29.

11.

Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.

Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.

Hum Brain Mapp. 2015 Jul;36(7):2592-601. doi: 10.1002/hbm.22793. Epub 2015 Mar 18.

PMID:
25788222
12.

Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.

Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA, London ED, Jentsch JD.

J Neurosci. 2012 Apr 25;32(17):5843-52. doi: 10.1523/JNEUROSCI.0029-12.2012.

13.

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.

Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.

Neurobiol Dis. 2011 Jun;42(3):391-403. doi: 10.1016/j.nbd.2011.01.033. Epub 2011 Feb 15.

PMID:
21303698
14.

Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.

Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P.

Synapse. 2010 Apr;64(4):313-22. doi: 10.1002/syn.20730.

PMID:
19957365
15.

Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease.

Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J.

J Neurochem. 2005 Jun;93(5):1057-68.

16.
17.

Interaction between LSD and dopamine D2/3 binding sites in pig brain.

Minuzzi L, Nomikos GG, Wade MR, Jensen SB, Olsen AK, Cumming P.

Synapse. 2005 Jun 15;56(4):198-204.

PMID:
15803496
18.

Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors.

Rouge-Pont F, Usiello A, Benoit-Marand M, Gonon F, Piazza PV, Borrelli E.

J Neurosci. 2002 Apr 15;22(8):3293-301.

19.

PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.

Cervenka S, Varrone A, Fransén E, Halldin C, Farde L.

Synapse. 2010 Jun;64(6):478-85. doi: 10.1002/syn.20765.

PMID:
20175222
20.

A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.

Su P, Li S, Chen S, Lipina TV, Wang M, Lai TK, Lee FH, Zhang H, Zhai D, Ferguson SS, Nobrega JN, Wong AH, Roder JC, Fletcher PJ, Liu F.

Neuron. 2014 Dec 17;84(6):1302-16. doi: 10.1016/j.neuron.2014.11.007. Epub 2014 Nov 26.

Supplemental Content

Support Center